We are live on ! Find out more
CBAY

Cymabay Therapeutics
CBAY

Delisted

CBAY was delisted on the 21st of March, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of CBAY yet.

CBAY Hedge Fund Activity: Q2 2024 in Review

0 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Cymabay Therapeutics (CBAY) for Q2 2024, worth a combined $0 — down 100% from $21.1K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of CBAY and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was IFP Advisors, exiting entirely with an estimated $21.1K sold.

  • 0 institutional investors held Cymabay Therapeutics (CBAY) as of Q2 2024, down from 1 in Q1 2024.
  • Funds reported $0 of Cymabay Therapeutics stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Cymabay Therapeutics positions in Q2 2024 and 1 closed out, a net change of -1 holder.
  • The largest Cymabay Therapeutics seller in Q2 2024 was IFP Advisors, an estimated $21.1K sold.

Based on aggregated 13F filings for Q2 2024.